K023592

Substantially Equivalent

SERAQUEST ANTI-THYROGLOBULIN

Applicant: Quest Intl., Inc.
Product code: DDC
Advisory panel: Immunology
Date received: 2002-10-25
Decision date: 2003-01-06
Decision: Substantially Equivalent
Clearance type: Traditional
Location: North Miami, FL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.